Insider Trading History of Gregory Richard J.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Gregory Richard J. since 2016. The trader's CIK number is 1629767. At the time of the last reporting, Gregory Richard J. was the Executive VP & CSO of Homology Medicines, Inc.. (stock ticker symbol FIXX). Also see all insider trading activities at Homology Medicines, Inc..

Note that in the past Gregory Richard J. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Homology Medicines, Inc. (FIXX) by Gregory Richard J.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 FIXX 0 $0 0 $0 10,806 $324

Yearly summary of insider trading at Immunogen, Inc. (IMGN) by Gregory Richard J.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 IMGN 0 $0 39,681 $221,213 0 $0
2018 IMGN 0 $0 37,390 $394,495 0 $0
2016 IMGN 16,600 $29,597 2,369 $26,305 0 $0


Insider trading activities at 2 companies by Gregory Richard J.:

1. Homology Medicines, Inc. (FIXX)

2. Immunogen, Inc. (IMGN)

Table 1. Insider trading of Homology Medicines, Inc. (FIXX) by Gregory Richard J.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-11-18 FIXX Option Ex 10,806 .03 324

Table 2. Insider trading of Immunogen, Inc. (IMGN) by Gregory Richard J.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-02-22 IMGN Sale 36,643 5.60 205,200
2019-01-07 IMGN Sale 3,038 5.27 16,013
2018-02-21 IMGN Sale 34,486 10.88 375,207
2017-01-08 IMGN Sale 2,904 6.64 19,288
2016-11-02 IMGN Buy 16,600 1.78 29,597
2016-01-08 IMGN Sale 2,369 11.10 26,305

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gregory Richard J. (Executive VP & CSO of Homology Medicines, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.